ResMed Inc. Financials

Market Capitalization $36.53 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	33.01
Forward PE	24.19
Price to Sales TTM	$7.60
Price to Book MRQ	$7.03
Enterprise to Revenue	7.68
Enterprise to EBITDA	22.63

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2021-06-30
Most Recent Quarter	2024-09-30
Profit Margin	23.15%
Operating Margin	31.63%
Return on Assets TTM	13.27%
Return on Equity TTM	23.57%

Income Statement

Revenue TTM	$4,807,484,928
Revenue per Share TTM	$32.71
Quarterly Revenue Growth	11.10%
Gross Profit TTM	$2,804,186,880
EBITDA	$1,694,249,000
Net Income to Common TTM	$1,112,883,968
Diluted EPS TTM	$7.54
Quarterly Earnings Growth YoY	41.90%

Balance Sheet

Total Cash MRQ	$442,576,992
Total Cash per Share MRQ	$3.02
Total Debt MRQ	$
Total Debt to Equity MRQ	16.37
Current Ratio MRQ	2.92
Book Value per Share MRQ	$35.39

Cash Flow

Operating Cash Flow TTM	$1,440,514,944
Levered Free Cash Flow TTM	$1,120,541,440

RMD Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	146,796,000
Float Shares	145,847,445
Avg 10 Volume	837,090
Avg 30 Volume	None
Shares Short	7,908,131
Short Ratio	10.63
Short % of Shares	6.20%
% Held by Insiders	0.77%
% Held by Institutions	61.37%

Stock Price Summary

Beta	0.69
Fifty Two Week Low	$170.56
Fifty Two Week High	$260.49
Fifty Two Week Change	23.66%
Day 50 MA	$239.53
Day 200 MA	$224.38

Dividends and Splits

Forward Annual Dividend Rate	$2.12
Forward Annual Dividend Yield	0.85%
Trailing Annual Dividend Rate	$2.02
Trailing Annual Dividend Yield	0.81%
Payout Ratio	26.13%
Dividend Date	2024-12-12
Ex Dividend Date	2024-11-07
Last Split Factor
Last Split Date	2010-08-31